Medical liability reform is gaining more attention as critical for ensuring access to care and spurring development of new medical treatments.
WASHINGTON, D.C.-Medical liability reform is gaining more attention as critical for ensuring access to care and spurring development of new medical treatments.
A liability protection provision, for example, was included in legislation that Congress approved in December to launch the administration's Pandemic Influenza plan. Language providing liability protection for manufacturers of pandemic countermeasures was added to the $453 billion 2006 defense appropriations bill, which provides $3.8 billion to support national emergency preparedness and the development of new vaccines and drugs.
BROAD MEASURE
Separately, an analysis of emergency medical care across the country down-rates many states due to their poor "medical liability environment," according to the American College of Emergency Physicians (ACEP).
In developing a report card on the nation's emergency medicine capabilities, ACEP gave points to states that have adopted caps on non-economic damage awards.
The report card also rates states on three other measures: access to emergency care; quality and patient safety; and public health and injury prevention.
These categories evaluate a state's percentage of uninsured; availability of hospital beds and emergency specialists; access to ambulances and 911 services; local injury prevention programs; and immunization rates. Only a handful of states received "B" ratings, while most scored only "Cs" and "Ds."
Bridging the Diversity Gap in Rare Disease Clinical Trials with Harsha Rajasimha of IndoUSrare
November 8th 2023Briana Contreras, an editor with Managed Healthcare Executive, spoke with Harsha Rajasimha, MD, founder and executive chairman of IndoUSrare, in this month's episode of Tuning in to the C-Suite podcast. The conversation was about how the disparity in diversity and ethnicity in rare disease clinical trials in the U.S. has led to gaps in understanding diseases and conditions, jeopardizing universal health, and increasing the economic burden of healthcare.
Listen
35th World AIDS Day Marks 20 Years of PEPFAR: Challenges and Strategies to Combat HIV/AIDS
November 29th 2023PEPFAR, having invested $100 billion and saved 25 million lives in the global fight against HIV/AIDS, faces Congressional hurdles in its reauthorization due to abortion debates. Despite widespread support and no evidence of abortion-related activities, the legislative process is at a standstill. Members of PEPFAR and authors of a recent editorial stress the significance of PEPFAR and advocate for integrating behavioral and social science into healthcare programs to achieve UNAIDS targets and address barriers in HIV/AIDS testing and treatment.
Read More
Managing Editor of Managed Healthcare Executive, Peter Wehrwein, had a discussion with William Shrank, M.D., a venture partner with Andreessen Horowitz, a venture capital firm in Menlo Park, California, about how artificial intelligence's role is improving healthcare, where we are today with value-based care and the ongoing efforts of reducing waste in the healthcare space for this episode of the "What's on Your Mind" podcast series.
Listen
Study Raises Concerns Over Insurance Barriers to HIV Prevention Medications
November 29th 2023Despite its efficacy, PrEP remains underutilized compared to the need for it. High costs are among the barriers to PrEP use, along with limited knowledge among clinicians, lack of health insurance, stigma, and underestimation of personal HIV risk.
Read More